- United States
- /
- Machinery
- /
- NYSE:IR
Does Ingersoll Rand's (IR) Modest Dividend Reveal Its True Capital Allocation Priorities?
Reviewed by Sasha Jovanovic
- The Board of Directors of Ingersoll Rand Inc. recently declared a regular quarterly cash dividend of $0.02 per share, payable on December 4, 2025, to stockholders of record as of November 13, 2025.
- This announcement comes just before the company is set to release its Q3 results, with analysts expecting continued revenue growth and positive earnings momentum.
- Given the upcoming earnings release and analysts' stable consensus, we'll examine what this means for Ingersoll Rand's investment narrative.
The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
Ingersoll Rand Investment Narrative Recap
To be a confident Ingersoll Rand shareholder today, you need to believe in the company's ability to steadily grow earnings through innovation in sustainable equipment and expansion of recurring revenue streams, while effectively managing acquisition-related risks and navigating industry cycles. The newly declared $0.02 per share quarterly dividend reinforces Ingersoll Rand’s stable capital return policy, but does not materially affect the biggest near-term catalyst, the pending Q3 earnings report, or mitigate key risks related to ongoing M&A execution and global trade volatility.
Among the company’s recent announcements, the upcoming Q3 2025 results are the most relevant, as analysts currently forecast year-on-year revenue growth and positive earnings momentum. This earnings release will offer clearer insight into whether the business is maintaining operational consistency and margin discipline, especially given continued challenges in organic order growth and industrial demand, which remain at the core of the investment narrative.
But even with the upcoming earnings update, investors should be alert to how prolonged trade uncertainty or customer hesitancy might still impact future results...
Read the full narrative on Ingersoll Rand (it's free!)
Ingersoll Rand's outlook points to $8.8 billion in revenue and $1.4 billion in earnings by 2028. This scenario assumes a 6.1% annual revenue growth rate and an earnings increase of about $877 million from the current $522.6 million level.
Uncover how Ingersoll Rand's forecasts yield a $90.00 fair value, a 14% upside to its current price.
Exploring Other Perspectives
Simply Wall St Community members have published four fair value estimates for Ingersoll Rand ranging from US$86.46 to US$121.47 per share. While views differ on valuation, many are watching how the company’s international expansion and M&A ambitions could influence its longer-term earnings profile; it’s worth considering the range of perspectives available.
Explore 4 other fair value estimates on Ingersoll Rand - why the stock might be worth as much as 54% more than the current price!
Build Your Own Ingersoll Rand Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Ingersoll Rand research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
- Our free Ingersoll Rand research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ingersoll Rand's overall financial health at a glance.
Curious About Other Options?
Our top stock finds are flying under the radar-for now. Get in early:
- Uncover the next big thing with financially sound penny stocks that balance risk and reward.
- Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.
- AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:IR
Ingersoll Rand
Provides various mission-critical air, fluid, energy, and medical technologies services and solutions worldwide.
Adequate balance sheet with moderate growth potential.
Similar Companies
Market Insights
Community Narratives
